Meeting
2022 ASCO Annual Meeting
Distinct mutational landscapes characterize melanomas metastatic to different anatomical sites.
Authors
Mahesh Y. Iddawela
Alfred Health, Central Clinical School,Monash University, Melbourne, VIC, Australia
Mahesh Y. Iddawela , Benjamin G Kaplan , Ray Greenstein , Peinan Zhao , Mark J. Shackleton , Richard S.P. Huang , Miles Cameron Andrews
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9562)
DOI
10.1200/JCO.2022.40.16_suppl.9562
Abstract #
9562
Poster Bd #
155
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2019 ASCO Annual Meeting
Molecular profiling of melanoma brain metastases (MBM) compared to primary cutaneous melanoma (CM).
First Author: Gino Kim In
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton